Skip to main content
SpringerLink
Log in

Surgical Treatment of Massive Subretinal Hemorrhage

  • Chapter
  • First Online:
Management of Macular Hemorrhage

  • 459 Accesses

Abstract

Subretinal mass hemorrhage due to exudative age-related macular degeneration remains a challenging field for submacular surgery. While small hemorrhages can be easily displaced by various pneumatic techniques, the correct strategy for massive subretinal bleeding is still under debate. This article reviews the different techniques for these severe cases and judges the visual prognosis and potential complications. In general, invasive techniques for extraction of the neovascular membrane with or without macular translocation or RPE-choroid patch translocation have the potential to achieve visual improvement. However, the risk of severe visual loss due to subsequent complications has to be weighed. By far better visual results with a significantly lower complication rate can be achieved with a two-step strategy using rTPA-assisted dissolution of the hemorrhage and evacuation of the liquefied clot via a small retinotomy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ritzau-Tondrow U, Baraki H, Hoerauf H. [Minimally invasive therapy of submacular hemorrhage in exsudative age-related macular degeneration]. Ophthalmologe. 2012;109(7):670–5.

    Article  CAS  Google Scholar 

  2. Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology [Clinical Trial Multicenter Study]. 1999;106(10):1900–6; discussion 1906–7.

    CAS  Google Scholar 

  3. Vander JF. Tissue plasminogen activator irrigation to facilitate removal of subretinal hemorrhage during vitrectomy. Ophthalmic Surg [Case Reports]. 1992;23(5):361–3.

    CAS  Google Scholar 

  4. de Juan E Jr, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. [Case Reports Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. 1988;105(1):25–9.

    Google Scholar 

  5. Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA. Surgical management of subfoveal choroidal neovascularization. Ophthalmology. [Case Reports Research Support, Non-U.S. Gov’t]. 1992;99(6):952–68; discussion 75–6.

    CAS  Google Scholar 

  6. Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology. [Clinical Trial Multicenter Study Randomized Controlled Trial Research Support, U.S. Gov’t, P.H.S.]. 2004;111(11):1993–2006.

    Google Scholar 

  7. Falkner CI, Leitich H, Frommlet F, Bauer P, Binder S. The end of submacular surgery for age-related macular degeneration? A meta-analysis. Graefes Arch Clin Exp Ophthalmol [Meta-Analysis]. 2007;245(4):490–501.

    Article  Google Scholar 

  8. Thompson JT, Sjaarda RN. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement. Trans Am Ophthalmol Soc [Comparative Study Evaluation Studies]. 2005;103:98–107; discussion.

    Google Scholar 

  9. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol [Case Reports Research Support, Non-U.S. Gov’t]. 1993;231(11):635–41.

    Article  CAS  Google Scholar 

  10. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol [Comparative Study]. 1999;237(4):313–25.

    Article  CAS  Google Scholar 

  11. Wong D, Stanga P, Briggs M, Lenfestey P, Lancaster E, Li KK, et al. Case selection in macular relocation surgery for age related macular degeneration. Br J Ophthalmol [Research Support, Non-U.S. Gov’t]. 2004;88(2):186–90.

    CAS  Google Scholar 

  12. Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol. 2002;134(4):560–5.

    Article  Google Scholar 

  13. Aisenbrey S, Lafaut BA, Szurman P, Grisanti S, Luke C, Krott R, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. 2002;120(4):451–9.

    Article  Google Scholar 

  14. Aisenbrey S, Bartz-Schmidt KU, Walter P, Hilgers RD, Ayertey H, Szurman P, et al. Long-term follow-up of macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol [Research Support, Non-U.S. Gov’t]. 2007;125(10):1367–72.

    Google Scholar 

  15. Joussen AM, Heussen FM, Joeres S, Llacer H, Prinz B, Rohrschneider K, et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol [Research Support, Non-U.S. Gov’t]. 2006;142(1):17–30.

    Google Scholar 

  16. van Meurs JC, Van Den Biesen PR. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol. 2003;136(4):688–95.

    Article  Google Scholar 

  17. Gibran SK, Romano MR, Wong D. Perfluorocarbon liquid assisted large retinal epithelium patching in sub-macular hemorrhage secondary to age related macular degeneration. Graefes Arch Clin Exp Ophthalmol [Clinical Trial]. 2009;247(2):187–91.

    Article  CAS  Google Scholar 

  18. Szurman P. [Subretinal surgery for massive hemorrhage]. Ophthalmologe. 2012;109(7):657–64.

    Article  CAS  Google Scholar 

  19. van Zeeburg EJ, Maaijwee KJ, TO M, Heimann H, van Meurs JC. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am J Ophthalmol [Research Support, Non-U.S. Gov’t]. 2012;153(1):120–7e2.

    Google Scholar 

  20. Maaijwee K, Heimann H, Missotten T, Mulder P, Joussen A, van Meurs J. Retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: long-term results. Graefes Arch Clin Exp Ophthalmol [Research Support, Non-U.S. Gov’t]. 2007;245(11):1681–9.

    Article  Google Scholar 

  21. Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996;121(3):267–75.

    Article  CAS  Google Scholar 

  22. Oshima Y, Ohji M, Tano Y. Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage. Br J Ophthalmol [Evaluation Studies Research Support, Non-U.S. Gov’t]. 2007;91(2):193–8.

    CAS  Google Scholar 

  23. Luke M, Januschowski K, Warga M, Beutel J, Leitritz M, Gelisken F, et al. The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator. Br J Ophthalmol. 2007;91(8):1077–82.

    Article  Google Scholar 

  24. Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. 2012;119(7):1388–98.

    Google Scholar 

  25. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. [Clinical Trial, Phase III Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 2012;119(12):2537–48.

    Google Scholar 

  26. van Zeeburg EJ, van Meurs JC. Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration. Ophthalmol J [Research Support, Non-U.S. Gov’t Review]. 2013;229(1):1–14.

    Google Scholar 

  27. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol. 1999;128(6):739–46.

    Article  CAS  Google Scholar 

  28. Kwan AS, Vijayasekaran S, McAllister IL, Yu PK, Yu DY. A study of retinal penetration of intravitreal tenecteplase in pigs. Invest Ophthalmol Vis Sci [Research Support, Non-U.S. Gov’t]. 2006;47(6):2662–7.

    Article  Google Scholar 

  29. Lincoff H, Madjarov B, Lincoff N, Movshovich A, Saxena S, Coleman DJ, et al. Pathogenesis of the vitreous cloud emanating from subretinal hemorrhage. Arch Ophthalmol [Research Support, Non-U.S. Gov’t]. 2003;121(1):91–6.

    Google Scholar 

  30. McAllister IL, Vijayasekaran S, Yu DY. Intravitreal tenecteplase (metalyse) for acute management of retinal vein occlusions. Invest Ophthalmol Vis Sci. [Research Support, Non-U.S. Gov’t]. 2013;54(7):4910–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eye Clinic Sulzbach, Sulzbach/Saar, Germany

    Peter Szurman M.D. & Kai Januschowski M.D.

  2. Center for ophthalmology, Eberhard-Karls University, Tuebingen, Germany

    Peter Szurman M.D. & Kai Januschowski M.D.

Authors
  1. Peter Szurman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai Januschowski M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Szurman M.D. .

Editor information

Editors and Affiliations

  1. Augenklinik des Klinikums Ludwigshafen, Ludwigshafen, Germany

    Lars-Olof Hattenbach

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Szurman, P., Januschowski, K. (2018). Surgical Treatment of Massive Subretinal Hemorrhage. In: Hattenbach, LO. (eds) Management of Macular Hemorrhage. Springer, Cham. https://doi.org/10.1007/978-3-319-65877-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65877-3_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65875-9

  • Online ISBN: 978-3-319-65877-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation